Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,268.98
(
0.33%
)
News Focus
News Focus
Post# of 3912
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 149
Posts 26280
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: runncoach post# 2033

Saturday, 07/31/2021 3:25:45 PM

Saturday, July 31, 2021 3:25:45 PM

Post# of 3912
Anavex designed and the FDA approve that design of a Phase 2b/3 trial with the inclusion criteria of subjects with a baseline MMSE score of between 20 and 28 inclusive.

Let's wait and see the inclusion criteria for the Cassava Phase 2b/3 trial. I bet that the inclusion criteria includes a baseline MMSE score of between 20 and 28 inclusive.

GOD bless,
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent FLNA News
More FLNA News